Live Breaking News & Updates on Vega Stultz

Stay updated with breaking news from Vega stultz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Women in Science: Katherine Vega Stultz on Ocelot's plans and fostering her 'CEO sisterhood' at Bio International

Katherine Vega Stultz is the CEO and president of Ocelot Bio, a clinical-stage biotech company focused on the development of therapeutics to treat complications of end-stage liver disease. ....

United States , Vega Stultz , Eli Lilly , Bio International , Bio Pharma Reporter At International , Bristol Myers Squibb , Graphite Bio , Bio Pharma Reporter , Ocelot Bio , Getty Images , Bio Developments , Biopharma Culture , Liver Disease , Clinical Trials ,

Kronos Bio Reports Recent Business Progress and First-Quarter 2023 Financial Results

Enrollment ongoing in expansion portion of Phase 1/2 KB-0742 study, with initial efficacy data expected in 2H 2023 Phase 1b/2 study of lanraplenib in combination with gilteritinib in FLT3-mutated AML. | May 10, 2023 ....

United Kingdom , Sarah Connors , Norbert Bischofberger , Kronos Bio , Roger Dansey , Leo Vartorella David Rosen , Katherine Vega Stultz , Claudia Styslinger , Bristol Myers Squibb , Gilead Sciences , Company Updates , Merck Co Inc , Exchange Commission , Corporate Communications , Kronos Bio Inc , Company Contact , Development Of Seagen Inc , Eli Lilly Company , Vega Stultz , Recent Company Updates , Chief Executive Officer , Chief Operating Officer , Graphite Bio , Eli Lilly , Senior Vice President , Cash Equivalents ,

Kronos Bio Announces Changes to Board of Directors

Katherine Vega Stultz appointed to Board Current Board member Otello Stampacchia, Ph.D., stepped down SAN MATEO, Calif. and CAMBRIDGE, Mass., April 11, 2023 Kronos Bio, Inc. , a company. | June 20, 2023 ....

United Kingdom , Kronos Bio , Otello Stampacchia , Claudia Styslinger , Katherine Vega Stultz , David Rosen , Leo Vartorella , Norbert Bischofberger , Globenewswire Inc , Cornell University , Kronos Bio Inc , Eli Lilly Company , Vega Stultz , Chief Executive Officer , Kronos Bio Board , Chief Operating Officer , General Manager , Corporate Vice President , Portfolio Management , Executive Director , Global Project Leader , Eli Lilly ,